Microbiota and Drug Response in Inflammatory Bowel Disease
A mutualistic relationship between the composition, function and activity of the gut microbiota (GM) and the host exists, and the alteration of GM, sometimes referred as dysbiosis, is involved in various immune-mediated diseases, including inflammatory bowel disease (IBD). Accumulating evidence sugg...
Main Authors: | Martina Franzin, Katja Stefančič, Marianna Lucafò, Giuliana Decorti, Gabriele Stocco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/2/211 |
Similar Items
-
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
by: Marianna Lucafò, et al.
Published: (2021-05-01) -
Fecal microbiota transplant – a new frontier in inflammatory bowel disease
by: Sunkara T, et al.
Published: (2018-08-01) -
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
by: Pufang Tan, et al.
Published: (2020-09-01) -
Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
by: Dikhnah Alshehri, et al.
Published: (2020-09-01) -
Improvement in Clinical Symptoms and Fecal Microbiome After Fecal Microbiota Transplantation in a Dog with Inflammatory Bowel Disease
by: Niina A, et al.
Published: (2019-12-01)